GENE ONLINE|News &
Opinion
Blog

LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop “Off-the-Shelf” CAR-iMAC Cell Therapy
2022-09-26
ODAC Votes Against Oncopeptides’ and Spectrum’s New Oncology Drugs
2022-09-26
Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases
2022-09-25
AstraZeneca’s Rare Disease Treatment Wins Third Approval in European Union
2022-09-23
AstraZeneca Blocks Ionis’ Hypercholesterolemia Treatment from Moving into a Phase 3 Study
2022-09-23
Allen Institute Launches Next Phase of Mapping the Human Brain With $173 Million
2022-09-23
Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities
2022-09-23
1 2 3 164
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!